Needham & Company LLC reissued their buy rating on shares of Danaher (NYSE:DHR) in a research note issued to investors on Friday morning, Briefing.com Automated Import reports. They currently have a $155.00 price objective on the conglomerate’s stock, up from their prior price objective of $142.00.
Other equities analysts have also recently issued reports about the stock. Piper Jaffray Companies raised shares of Post from a neutral rating to an overweight rating and boosted their price objective for the company from $106.00 to $130.00 in a research note on Thursday, July 18th. Zacks Investment Research cut shares of GALP ENERGIA SG/ADR from a hold rating to a sell rating in a research note on Monday, May 6th. Wolfe Research started coverage on shares of Waters in a research note on Thursday, May 30th. They issued an underperform rating on the stock. Finally, Janney Montgomery Scott boosted their price objective on shares of Danaher from $136.00 to $174.00 and gave the company a buy rating in a research note on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $139.08.
Shares of Danaher stock opened at $141.62 on Friday. The firm has a fifty day simple moving average of $140.84. The firm has a market cap of $101.59 billion, a PE ratio of 31.33, a price-to-earnings-growth ratio of 2.56 and a beta of 0.96. Danaher has a 12 month low of $94.59 and a 12 month high of $145.50. The company has a quick ratio of 1.91, a current ratio of 2.32 and a debt-to-equity ratio of 0.33.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.17 dividend. The ex-dividend date is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.48%. Danaher’s dividend payout ratio is currently 15.04%.
In other Danaher news, Director Alan G. Spoon sold 1,913 shares of the business’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total transaction of $247,771.76. Following the sale, the director now directly owns 86,863 shares in the company, valued at approximately $11,250,495.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the business’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $131.30, for a total transaction of $24,143,181.40. Following the sale, the chief executive officer now owns 302,377 shares in the company, valued at $39,702,100.10. The disclosure for this sale can be found here. Insiders sold a total of 453,448 shares of company stock worth $59,724,640 over the last three months. 11.40% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the business. Geode Capital Management LLC boosted its position in Danaher by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock valued at $774,743,000 after buying an additional 583,194 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in Danaher during the fourth quarter valued at about $5,115,000. MML Investors Services LLC boosted its position in Danaher by 14.3% during the fourth quarter. MML Investors Services LLC now owns 11,279 shares of the conglomerate’s stock valued at $1,163,000 after buying an additional 1,415 shares during the period. Nuveen Asset Management LLC boosted its position in Danaher by 3.6% during the fourth quarter. Nuveen Asset Management LLC now owns 33,116 shares of the conglomerate’s stock valued at $3,415,000 after buying an additional 1,159 shares during the period. Finally, Sontag Advisory LLC purchased a new stake in Danaher during the fourth quarter valued at about $47,000. Institutional investors own 78.86% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Trade War
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.